𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is xamoterol safe in chronic airflow obstruction?

✍ Scribed by J. A. Roberts; V. F. Challenor; D. G. Waller


Book ID
104700454
Publisher
Springer
Year
1992
Tongue
English
Weight
341 KB
Volume
42
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


We have demonstrated in a group of 10 patients with CAO that treatment with xamoterol (200 mg b.i.d. for 7 days) did not alter lung function or respiratory symptoms. These results suggest that xamoterol can be used to treat mild heart failure in patients with CAO.


πŸ“œ SIMILAR VOLUMES


Muscarinic receptor binding in central a
✍ C.J. van Koppen; J.-W.J. Lammers; J.F.Rodrigues de Miranda; A.J. Beld; C.L.A. va πŸ“‚ Article πŸ“… 1989 πŸ› Elsevier 🌐 English βš– 519 KB

The hypothesis of an increased muscarinic receptor sensitivity in airway musculature of patients with chronic airflow obstruction (CAO) has been investigated by in vitro radioligand binding studies. The receptor binding profiles were determined in membrane homogenates of tracheal and main bronchial